Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EW4L
|
||||
Former ID |
DAP000867
|
||||
Drug Name |
Abatacept
|
||||
Synonyms |
Orencia (TN)
|
||||
Therapeutic Class |
Antirheumatic Agents
|
||||
Company |
Bristol-Myers Squibb
|
||||
CAS Number |
CAS 332348-12-6
|
||||
SuperDrug ATC ID |
L04AA24
|
||||
Target and Pathway | |||||
Target(s) | T-lymphocyte activation antigen CD80 | Target Info | Binder | [537606] | |
T-lymphocyte activation antigen CD86 | Target Info | Binder | [537606] | ||
KEGG Pathway | Cell adhesion molecules (CAMs) | ||||
Toll-like receptor signaling pathway | |||||
Intestinal immune network for IgA production | |||||
Type I diabetes mellitus | |||||
Autoimmune thyroid disease | |||||
Systemic lupus erythematosus | |||||
Rheumatoid arthritis | |||||
Allograft rejection | |||||
Graft-versus-host disease | |||||
Viral myocarditishsa04514:Cell adhesion molecules (CAMs) | |||||
Transcriptional misregulation in cancer | |||||
Viral myocarditis | |||||
PANTHER Pathway | T cell activationP00053:T cell activation | ||||
WikiPathways | Toll-like receptor signaling pathway | ||||
Inflammatory Response Pathway | |||||
PIP3 activates AKT signaling | |||||
Primary Focal Segmental Glomerulosclerosis FSGS | |||||
Allograft Rejection | |||||
Costimulation by the CD28 family | |||||
Regulation of toll-like receptor signaling pathwayWP75:Toll-like receptor signaling pathway | |||||
IL-3 Signaling Pathway | |||||
Regulation of toll-like receptor signaling pathway | |||||
References | |||||
Ref 536737 | Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54. | ||||
Ref 541949 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6891). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.